Search

everythinglearnresearchcommunity

for

Search:↓

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Targeting ornithine decarboxylase can help prevent skin cancer.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

The Megsin-Cre transgene is a new tool for genetic manipulation in the skin and upper digestive tract.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

CD200- cells in hair follicles have a higher ability to regenerate hair.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Touch dome keratinocytes in adult skin have traits of different skin cell types.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

A young woman with a rare skin cancer was diagnosed late because her symptoms were unusual for the disease.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

CTCF protein is essential for skin and hair follicle development in mice.

Immortalized human dermal papilla cells were created that grow better and can still help form hair.

CD61 is important for mouse tooth cell growth and works through Lgr5.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Different keratins have unique expression patterns in mouse skin cells.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Loss of Ten1 in mice causes telomere shortening and symptoms similar to human dyskeratosis congenita.

The new Brigatinib nanocarrier is more effective against lung cancer cells than the free drug.

The treatment was ineffective in humans.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.